Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.005 USD | -6.07% | -19.69% | +15.09% |
Apr. 15 | Faron Pharmaceuticals reappoints former finance chief on interim basis | AN |
Apr. 03 | Top Midday Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.09% | 106M | |
+4.01% | 43.43B | |
+47.81% | 41.69B | |
+8.99% | 41.31B | |
-10.92% | 27.14B | |
+8.94% | 25.28B | |
-24.63% | 18.47B | |
+29.41% | 12.59B | |
+1.26% | 12.33B | |
+9.27% | 11.03B |
- Stock Market
- Equities
- FGEN Stock
- News FibroGen, Inc.
- FDA Extends Review Period for FibroGen Amenia Treatment Until March 20: Shares Down Over 11% in Late Trade